BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duffy MJ, Sturgeon CM, Sölétormos G, Barak V, Molina R, Hayes DF, Diamandis EP, Bossuyt PM. Validation of new cancer biomarkers: a position statement from the European group on tumor markers. Clin Chem 2015;61:809-20. [PMID: 25882892 DOI: 10.1373/clinchem.2015.239863] [Cited by in Crossref: 91] [Cited by in F6Publishing: 60] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Horgan D, Ciliberto G, Conte P, Baldwin D, Seijo L, Montuenga LM, Paz-Ares L, Garassino M, Penault-Llorca F, Galli F, Ray-Coquard I, Querleu D, Capoluongo E, Banerjee S, Riegman P, Kerr K, Horbach B, Büttner R, Van Poppel H, Bjartell A, Codacci-Pisanelli G, Westphalen B, Calvo F, Koeva-Balabanova J, Hall S, Paradiso A, Kalra D, Cobbaert C, Varea Menendez R, Maravic Z, Fotaki V, Bennouna J, Cauchin E, Malats N, Gutiérrez-Ibarluzea I, Gannon B, Mastris K, Bernini C, Gallagher W, Buglioni S, Kent A, Munzone E, Belina I, Van Meerbeeck J, Duffy M, Sarnowska E, Jagielska B, Mee S, Curigliano G. Bringing Greater Accuracy to Europe's Healthcare Systems: The Unexploited Potential of Biomarker Testing in Oncology. Biomed Hub 2020;5:182-223. [PMID: 33564664 DOI: 10.1159/000511209] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Martin-Liberal J, Rodon J. Clinical research in small genomically stratified patient populations. Eur J Cancer 2017;80:73-82. [PMID: 28591680 DOI: 10.1016/j.ejca.2017.05.008] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Maxwell GL, Mutch DG. The promise of molecular staging for the future. Cancer 2017;123:728-30. [PMID: 28061001 DOI: 10.1002/cncr.30504] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Kwan EM, Fettke H, Crumbaker M, Docanto MM, To SQ, Bukczynska P, Mant A, Ng N, Foroughi S, Graham LK, Haynes AM, Azer S, Lim LE, Segelov E, Mahon K, Davis ID, Parente P, Pezaro C, Todenhöfer T, Sathianathen N, Hauser C, Horvath LG, Joshua AM, Azad AA. Whole blood GRHL2 expression as a prognostic biomarker in metastatic hormone-sensitive and castration-resistant prostate cancer. Transl Androl Urol 2021;10:1688-99. [PMID: 33968657 DOI: 10.21037/tau-20-1444] [Reference Citation Analysis]
5 Ravalli A, Voccia D, Palchetti I, Marrazza G. Electrochemical, Electrochemiluminescence, and Photoelectrochemical Aptamer-Based Nanostructured Sensors for Biomarker Analysis. Biosensors (Basel) 2016;6:E39. [PMID: 27490578 DOI: 10.3390/bios6030039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
6 Baker MJ, Hussain SR, Lovergne L, Untereiner V, Hughes C, Lukaszewski RA, Thiéfin G, Sockalingum GD. Developing and understanding biofluid vibrational spectroscopy: a critical review. Chem Soc Rev 2016;45:1803-18. [DOI: 10.1039/c5cs00585j] [Cited by in Crossref: 159] [Cited by in F6Publishing: 41] [Article Influence: 26.5] [Reference Citation Analysis]
7 Mamzer MF, Duchange N, Darquy S, Marvanne P, Rambaud C, Marsico G, Cerisey C, Scotté F, Burgun A, Badoual C, Laurent-Puig P, Hervé C. Partnering with patients in translational oncology research: ethical approach. J Transl Med 2017;15:74. [PMID: 28390420 DOI: 10.1186/s12967-017-1177-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
8 Gov E, Kori M, Arga KY. RNA-based ovarian cancer research from 'a gene to systems biomedicine' perspective. Syst Biol Reprod Med 2017;63:219-38. [PMID: 28574782 DOI: 10.1080/19396368.2017.1330368] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
9 Geyer PE, Holdt LM, Teupser D, Mann M. Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol 2017;13:942. [PMID: 28951502 DOI: 10.15252/msb.20156297] [Cited by in Crossref: 286] [Cited by in F6Publishing: 239] [Article Influence: 57.2] [Reference Citation Analysis]
10 Figueira I, Godinho-Pereira J, Galego S, Maia J, Haskó J, Molnár K, Malhó R, Costa-Silva B, Wilhelm I, Krizbai IA, Brito MA. MicroRNAs and Extracellular Vesicles as Distinctive Biomarkers of Precocious and Advanced Stages of Breast Cancer Brain Metastases Development. Int J Mol Sci 2021;22:5214. [PMID: 34069135 DOI: 10.3390/ijms22105214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Asensio AF, Sierra L, Montes-bayón M, Blanco-gonzález E. Sensitive determination of the human epidermal growth factor receptor 2 (HER2) by immuno-polymerase chain reaction with inductively coupled plasma-mass spectrometry detection. Analytica Chimica Acta 2019;1090:39-46. [DOI: 10.1016/j.aca.2019.09.047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
12 Wong KM, Capasso A, Eckhardt SG. The changing landscape of phase I trials in oncology. Nat Rev Clin Oncol 2016;13:106-17. [DOI: 10.1038/nrclinonc.2015.194] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 7.9] [Reference Citation Analysis]
13 Duffy MJ, O'donovan N, Mcdermott E, Crown J. Validated biomarkers: The key to precision treatment in patients with breast cancer. The Breast 2016;29:192-201. [DOI: 10.1016/j.breast.2016.07.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
14 Niegisch G. Predicting immune checkpoint inhibitor response in urothelial carcinoma: another step in personalised medicine? Br J Cancer 2020;122:453-4. [PMID: 31857721 DOI: 10.1038/s41416-019-0684-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Abu Hassan SO, Nielsen DL, Tuxen MK, Petersen PH, Sölétormos G. Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period. Future Sci OA 2017;3:FSO216. [PMID: 28884012 DOI: 10.4155/fsoa-2017-0023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
16 Bosch X, Molina R, Marrades R, Augé JM, Pellicé M, López-Soto A. Tumour markers with clinically controlled cut-offs for suspected cancer. Eur J Clin Invest 2021;51:e13523. [PMID: 33594702 DOI: 10.1111/eci.13523] [Reference Citation Analysis]
17 Zhao Z, Fan J, Hsu YS, Lyon CJ, Ning B, Hu TY. Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application. Lab Chip 2019;19:1114-40. [PMID: 30882822 DOI: 10.1039/c8lc01123k] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 12.0] [Reference Citation Analysis]
18 Lindeman NI, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, Colasacco C, Dacic S, Hirsch FR, Kerr K, Kwiatkowski DJ, Ladanyi M, Nowak JA, Sholl L, Temple-Smolkin R, Solomon B, Souter LH, Thunnissen E, Tsao MS, Ventura CB, Wynes MW, Yatabe Y. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. J Mol Diagn 2018;20:129-59. [PMID: 29398453 DOI: 10.1016/j.jmoldx.2017.11.004] [Cited by in Crossref: 117] [Cited by in F6Publishing: 121] [Article Influence: 29.3] [Reference Citation Analysis]
19 Saichua P, Yakovleva A, Kamamia C, Jariwala AR, Sithithaworn J, Sripa B, Brindley PJ, Laha T, Mairiang E, Pairojkul C, Khuntikeo N, Mulvenna J, Sithithaworn P, Bethony JM. Levels of 8-OxodG Predict Hepatobiliary Pathology in Opisthorchis viverrini Endemic Settings in Thailand. PLoS Negl Trop Dis 2015;9:e0003949. [PMID: 26230769 DOI: 10.1371/journal.pntd.0003949] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
20 Harmon SA, Patel PG, Sanford TH, Caven I, Iseman R, Vidotto T, Picanço C, Squire JA, Masoudi S, Mehralivand S, Choyke PL, Berman DM, Turkbey B, Jamaspishvili T. High throughput assessment of biomarkers in tissue microarrays using artificial intelligence: PTEN loss as a proof-of-principle in multi-center prostate cancer cohorts. Mod Pathol 2021;34:478-89. [PMID: 32884130 DOI: 10.1038/s41379-020-00674-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Arana Echarri A, Beresford M, Campbell JP, Jones RH, Butler R, Gollob KJ, Brum PC, Thompson D, Turner JE. A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling. Front Immunol 2020;11:616188. [PMID: 33597950 DOI: 10.3389/fimmu.2020.616188] [Reference Citation Analysis]
22 Fonnes T, Berg HF, Bredholt T, Edqvist PD, Sortland K, Berg A, Salvesen HB, Akslen LA, Werner HMJ, Trovik J, Tangen IL, Krakstad C. Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions. Gynecol Oncol 2018;148:197-203. [PMID: 29096882 DOI: 10.1016/j.ygyno.2017.10.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
23 Sears CR, Mazzone PJ. Biomarkers in Lung Cancer. Clin Chest Med 2020;41:115-27. [PMID: 32008624 DOI: 10.1016/j.ccm.2019.10.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
24 Su KY, Lee WL. Fourier Transform Infrared Spectroscopy as a Cancer Screening and Diagnostic Tool: A Review and Prospects. Cancers (Basel) 2020;12:E115. [PMID: 31906324 DOI: 10.3390/cancers12010115] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 14.0] [Reference Citation Analysis]
25 Selby PJ, Banks RE, Gregory W, Hewison J, Rosenberg W, Altman DG, Deeks JJ, Mccabe C, Parkes J, Sturgeon C, Thompson D, Twiddy M, Bestall J, Bedlington J, Hale T, Dinnes J, Jones M, Lewington A, Messenger MP, Napp V, Sitch A, Tanwar S, Vasudev NS, Baxter P, Bell S, Cairns DA, Calder N, Corrigan N, Del Galdo F, Heudtlass P, Hornigold N, Hulme C, Hutchinson M, Lippiatt C, Livingstone T, Longo R, Potton M, Roberts S, Sim S, Trainor S, Welberry Smith M, Neuberger J, Thorburn D, Richardson P, Christie J, Sheerin N, Mckane W, Gibbs P, Edwards A, Soomro N, Adeyoju A, Stewart GD, Hrouda D. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT. Programme Grants Appl Res 2018;6:1-528. [DOI: 10.3310/pgfar06030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Lindeman NI, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, Colasacco C, Dacic S, Hirsch FR, Kerr K, Kwiatkowski DJ, Ladanyi M, Nowak JA, Sholl L, Temple-smolkin R, Solomon B, Souter LH, Thunnissen E, Tsao MS, Ventura CB, Wynes MW, Yatabe Y. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors. Journal of Thoracic Oncology 2018;13:323-58. [DOI: 10.1016/j.jtho.2017.12.001] [Cited by in Crossref: 193] [Cited by in F6Publishing: 199] [Article Influence: 48.3] [Reference Citation Analysis]
27 Singh N, Huang L, Wang D, Shao N, Zhang X. Simultaneous Detection of a Cluster of Differentiation Markers on Leukemia-Derived Exosomes by Multiplex Immuno-Polymerase Chain Reaction via Capillary Electrophoresis Analysis. Anal Chem 2020;92:10569-77. [DOI: 10.1021/acs.analchem.0c01464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Miquel-cases A, Schouten PC, Steuten LM, Retèl VP, Linn SC, van Harten WH. (Very) Early technology assessment and translation of predictive biomarkers in breast cancer. Cancer Treatment Reviews 2017;52:117-27. [DOI: 10.1016/j.ctrv.2016.11.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
29 Kulasingam V, Prassas I, Diamandis EP. Towards personalized tumor markers. NPJ Precis Oncol 2017;1:17. [PMID: 29872704 DOI: 10.1038/s41698-017-0021-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
30 Hue JJ, Markt SC, Rao G, Winter JM. Patient-centered Weight Tracking as an Early Cancer Detection Strategy. J Cancer Prev 2020;25:181-8. [PMID: 33033712 DOI: 10.15430/JCP.2020.25.3.181] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Zaslavsky BY, Uversky VN, Chait A. Analytical applications of partitioning in aqueous two-phase systems: Exploring protein structural changes and protein–partner interactions in vitro and in vivo by solvent interaction analysis method. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2016;1864:622-44. [DOI: 10.1016/j.bbapap.2016.02.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
32 Macdonald IK, Parsy-Kowalska CB, Chapman CJ. Autoantibodies: Opportunities for Early Cancer Detection. Trends Cancer. 2017;3:198-213. [PMID: 28718432 DOI: 10.1016/j.trecan.2017.02.003] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 9.6] [Reference Citation Analysis]
33 Egatz-Gomez A, Wang C, Klacsmann F, Pan Z, Marczak S, Wang Y, Sun G, Senapati S, Chang HC. Future microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine. Biomicrofluidics 2016;10:032902. [PMID: 27190565 DOI: 10.1063/1.4948525] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
34 Halfter K, Mayer B. Bringing 3D tumor models to the clinic - predictive value for personalized medicine. Biotechnol J 2017;12. [PMID: 28098436 DOI: 10.1002/biot.201600295] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
35 Sakkas D, Ramalingam M, Garrido N, Barratt CL. Sperm selection in natural conception: what can we learn from Mother Nature to improve assisted reproduction outcomes? Hum Reprod Update 2015;21:711-26. [PMID: 26386468 DOI: 10.1093/humupd/dmv042] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 13.3] [Reference Citation Analysis]
36 Coşkun A, Aarsand AK, Sandberg S, Guerra E, Locatelli M, Díaz-Garzón J, Fernandez-Calle P, Ceriotti F, Jonker N, Bartlett WA, Carobene A; European Federation of Clinical Chemistry and Laboratory Medicine Working Group on Biological Variation. Within- and between-subject biological variation data for tumor markers based on the European Biological Variation Study. Clin Chem Lab Med 2021. [PMID: 33964202 DOI: 10.1515/cclm-2021-0283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Castaneda CA, Castillo M, Bernabe LA, Sanchez J, Casavilca S, García-Corrochano P, Ponce J, Villa-Robles MR, Lopez CB, Orrego E. Impact of pathological features of brain metastases in prognosis. Biomark Med 2018;12:475-85. [PMID: 29697273 DOI: 10.2217/bmm-2017-0161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
38 Dragani TA, Matarese V, Colombo F. Biomarkers for Early Cancer Diagnosis: Prospects for Success through the Lens of Tumor Genetics. Bioessays 2020;42:e1900122. [PMID: 32128843 DOI: 10.1002/bies.201900122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Mazzone PJ, Sears CR, Arenberg DA, Gaga M, Gould MK, Massion PP, Nair VS, Powell CA, Silvestri GA, Vachani A, Wiener RS; ATS Assembly on Thoracic Oncology. Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement. Am J Respir Crit Care Med 2017;196:e15-29. [PMID: 28960111 DOI: 10.1164/rccm.201708-1678ST] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
40 Erb U, Zöller M. Progress and potential of exosome analysis for early pancreatic cancer detection. Expert Rev Mol Diagn 2016;16:757-67. [PMID: 27206554 DOI: 10.1080/14737159.2016.1187563] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
41 Malczewska A, Kidd M, Matar S, Kos-Kudla B, Modlin IM. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology. 2018;107:73-90. [PMID: 29566385 DOI: 10.1159/000487326] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
42 Grenader T, Tauber R, Shavit L. Next-generation sequencing in patients with advanced cancer: are we ready for widespread clinical use? A single institute's experience. Anticancer Drugs 2016;27:899-907. [PMID: 27384593 DOI: 10.1097/CAD.0000000000000406] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 Sjöström M, Chang SL, Fishbane N, Davicioni E, Zhao SG, Hartman L, Holmberg E, Feng FY, Speers CW, Pierce LJ, Malmström P, Fernö M, Karlsson P. Clinicogenomic Radiotherapy Classifier Predicting the Need for Intensified Locoregional Treatment After Breast-Conserving Surgery for Early-Stage Breast Cancer. J Clin Oncol 2019;37:3340-9. [PMID: 31618132 DOI: 10.1200/JCO.19.00761] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 8.3] [Reference Citation Analysis]
44 Jezkova E, Zubor P, Kajo K, Grendar M, Dokus K, Adamkov M, Lasabova Z, Plank L, Danko J. Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients. Oncol Lett 2017;14:758-66. [PMID: 28693231 DOI: 10.3892/ol.2017.6204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
45 Partridge AH, Sepucha K, O'Neill A, Miller KD, Baker E, Dang CT, Northfelt DW, Sledge GW, Schneider BP. Does biomarker information impact breast cancer patients' preferences and physician recommendation for adjuvant chemotherapy? Breast Cancer Res Treat 2017;165:545-53. [PMID: 28646344 DOI: 10.1007/s10549-017-4338-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
46 van Rossum HH, Meng QH, Ramanathan LV, Holdenrieder S. A word of caution on using tumor biomarker reference change values to guide medical decisions and the need for alternatives. Clin Chem Lab Med 2021. [PMID: 34648697 DOI: 10.1515/cclm-2021-0933] [Reference Citation Analysis]
47 O DF, Fassbender A, Van Bree R, Laenen A, Peterse DP, Vanhie A, Waelkens E, D'Hooghe TM. Technical Verification and Assessment of Independent Validation of Biomarker Models for Endometriosis. Biomed Res Int 2019;2019:3673060. [PMID: 31428634 DOI: 10.1155/2019/3673060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
48 Miyahira AK, Lang JM, Den RB, Garraway IP, Lotan TL, Ross AE, Stoyanova T, Cho SY, Simons JW, Pienta KJ, Soule HR. Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting. Prostate 2016;76:125-39. [PMID: 26477609 DOI: 10.1002/pros.23107] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
49 Ku TH, Zhang T, Luo H, Yen TM, Chen PW, Han Y, Lo YH. Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing. Sensors (Basel) 2015;15:16281-313. [PMID: 26153774 DOI: 10.3390/s150716281] [Cited by in Crossref: 82] [Cited by in F6Publishing: 67] [Article Influence: 11.7] [Reference Citation Analysis]
50 Amacher DE. A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers. Biomarkers 2016;21:387-403. [PMID: 26983778 DOI: 10.3109/1354750X.2016.1153724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
51 do Nascimento JCF, Beltrão EIC, Rocha CRC. High FUT3 expression is a marker of lower overall survival of breast cancer patients. Glycoconj J 2020;37:263-75. [PMID: 32062822 DOI: 10.1007/s10719-020-09914-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Olsen M, Ghannad M, Lok C, Bossuyt PM. Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;58:3-10. [DOI: 10.1515/cclm-2019-0038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
53 Rolff HC, Christensen IJ, Svendsen LB, Wilhelmsen M, Lund IK, Thurison T, Høyer-Hansen G, Illemann M, Nielsen HJ; Danish Collaborative Research Group on Colorectal Cancer. The concentration of the cleaved suPAR forms in pre- and postoperative plasma samples improves the prediction of survival in colorectal cancer: A nationwide multicenter validation and discovery study. J Surg Oncol 2019;120:1404-11. [PMID: 31646652 DOI: 10.1002/jso.25733] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Music M, Prassas I, Diamandis EP. Optimizing cancer immunotherapy: Is it time for personalized predictive biomarkers? Crit Rev Clin Lab Sci 2018;55:466-79. [PMID: 30277835 DOI: 10.1080/10408363.2018.1499706] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
55 Viggiani V, Palombi S, Gennarini G, D’ettorre G, De Vito C, Angeloni A, Frati L, Anastasi E. Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients. Scandinavian Journal of Gastroenterology 2016;51:1257-62. [DOI: 10.1080/00365521.2016.1183705] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
56 Wu Y, Lu C, Pan N, Zhang M, An Y, Xu M, Zhang L, Guo Y, Tan L. Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases. Sci Rep 2021;11:12997. [PMID: 34155288 DOI: 10.1038/s41598-021-92430-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Fonnes T, Trovik J, Edqvist PH, Fasmer KE, Marcickiewicz J, Tingulstad S, Staff AC, Bjørge L, Amant F, Haldorsen IS, Werner H, Akslen LA, Tangen IL, Krakstad C. Asparaginase-like protein 1 expression in curettage independently predicts lymph node metastasis in endometrial carcinoma: a multicentre study. BJOG 2018;125:1695-703. [PMID: 29989298 DOI: 10.1111/1471-0528.15403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
58 Wang W, Chen XL, Zhao SY, Xu YH, Zhang WH, Liu K, Chen XZ, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma. Oncotarget. 2016;7:35423-35436. [PMID: 27097114 DOI: 10.18632/oncotarget.8770] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
59 Sparano JA, Gray RJ, Makower DF, Pritchard KI, Albain KS, Hayes DF, Geyer CE Jr, Dees EC, Perez EA, Olson JA Jr, Zujewski J, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Paik S, Wood WC, Ravdin P, Keane MM, Gomez Moreno HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Atkins JN, Berenberg JL, Sledge GW. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. N Engl J Med 2015;373:2005-14. [PMID: 26412349 DOI: 10.1056/NEJMoa1510764] [Cited by in Crossref: 751] [Cited by in F6Publishing: 376] [Article Influence: 107.3] [Reference Citation Analysis]
60 Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M, Keegan D, Hogg RE, Ambati BK. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res 2016;54:64-102. [PMID: 27156982 DOI: 10.1016/j.preteyeres.2016.04.003] [Cited by in Crossref: 140] [Cited by in F6Publishing: 130] [Article Influence: 23.3] [Reference Citation Analysis]
61 Robinson MR, Miller RA, Spellman DS. Mass Spectrometry-Based Biomarkers in Drug Development. Adv Exp Med Biol 2019;1140:435-49. [PMID: 31347063 DOI: 10.1007/978-3-030-15950-4_25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Byrne JA, Grima N, Capes-Davis A, Labbé C. The Possibility of Systematic Research Fraud Targeting Under-Studied Human Genes: Causes, Consequences, and Potential Solutions. Biomark Insights 2019;14:1177271919829162. [PMID: 30783377 DOI: 10.1177/1177271919829162] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]